Minireview: Delivering the code: Polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies

71Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

Nucleic acid-based therapies offer great potential for treatment of a variety of diseases including cancer by modulating protein expression with DNA or small interfering RNA. However, realization of their full therapeutic potential is currently limited due to an inability to reach the target site in an active form. Identification of delivery barriers such as stability in circulation, resistance to degradation and entrapment in subcellular vesicles has led to development of sophisticated multifunctional synthetic polymers for forming ionic complexes with nucleic acids and also providing performance-enhancing features. The most promising designs comprise features to help increase stability in circulation and also contain functionality to aid in endosome escape of nucleic acid cargo after cellular internalization. Copyright © 2010 by The Endocrine Society.

Cite

CITATION STYLE

APA

Christie, R. J., Nishiyama, N., & Kataoka, K. (2010). Minireview: Delivering the code: Polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies. Endocrinology. https://doi.org/10.1210/en.2009-1045

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free